COVID-19 vaccine development: milestones, lessons and prospects.
Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. · 2022
Read COVID-19 vaccine development: milestones, lessons and prospects. by Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9062866.txt.
Introduction
Li and co-authors review the development of COVID-19 vaccines, from milestones to lessons for the next emergency. The main platforms include inactivated, viral vector, protein, RNA, and DNA vaccines. Some designs stir extra layers of immunity, such as T helper and memory responses, that raise their power. The review weighs efficacy data platform by platform.
Safety gets a full hearing, including rare clotting and heart inflammation reports. The authors also assess vaccination in pregnancy, old age, cancer, and immune weakness. They recommend mix-and-match schedules and new designs, such as nanoparticle vaccines, to improve both safety and effect.
Catalog record
| CREATOR | Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 193 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |